Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neuroblastoma 4Multiple Myeloma 2Vaccinia 1Transplant-Related Hematologic Malignancy 1Recurrence 1Prostatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Medulloblastoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Kidney Neoplasms 1Hodgkin Disease 1Glioma 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Cyclophosphamide 5Specimen Handling 4Magnetic Resonance Spectroscopy 4Biopsy 4Nivolumab 3sodium-iodide symporter 2fludarabine 2cemiplimab 2X-Rays 2Whole-Body Irradiation 2Stem Cell Transplantation 2Photons 2Mycophenolic Acid 2Immunoglobulin G 2Disulfides 2Cyclosporine 210-propargyl-10-deazaaminopterin 2treosulfan 1talimogene laherparepvec 1sargramostim 1ruxolitinib 1pembrolizumab 1fludarabine phosphate 1entrectinib 1duvelisib 1ceritinib 1belinostat 1alectinib 1Vincristine 1Vinblastine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large-Cell, Anaplastic × Granulocyte-Macrophage Colony-Stimulating Factor × 90 days × Clear all
NCT05544968 2026-04-03

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Medical College of Wisconsin

Phase 1 Recruiting
42 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Neoplasms, Recurrence, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡